Strategies to Treat Osteoporosis Following a Fragility Fracture (OPTIMUS)
This study is ongoing, but not recruiting participants.
Université de Sherbrooke
Merck Sharp & Dohme Corp.
Procter and Gamble
Eli Lilly and Company
Information provided by (Responsible Party):
Gilles Boire, Université de Sherbrooke
First received: August 3, 2007
Last updated: October 30, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||June 2016|
|Primary Completion Date:||July 2013 (Final data collection date for primary outcome measure)|